Barclays Maintains Equal-Weight on Insulet, Raises Price Target to $165
Benzinga Newsdesk 4 hours ago
Analyst RatingsNewsPrice Target
Barclays analyst Christopher Pasquale maintains Insulet (NASDAQ:PODD) with a Equal-Weight and raises the price target from $150 to $165.
Barclays analyst Christopher Pasquale maintains Insulet (NASDAQ:PODD) with a Equal-Weight and raises the price target from $150 to $165.